From: Improvement of functioning in patients with schizophrenia: real-world effectiveness of aripiprazole once-monthly (REACT study)
Substance
Patients, n (%) (n = 396)
Quetiapine
25 (6.3)
Olanzapine
21 (5.3)
Clozapine
12 (3.0)
Risperidone